SCHEDULE: Lincoln Alternative Strategies Discloses 6.9% Stake in STRATA Skin Sciences

Lincoln Alternative Strategies LLC has reported a 6.9% beneficial ownership stake in STRATA Skin Sciences, Inc., holding 365,849 shares of common stock.

Summary

• Lincoln Alternative Strategies LLC has filed a Schedule 13G, disclosing beneficial ownership of 365,849 shares of STRATA Skin Sciences, Inc. common stock.
• This ownership represents 6.9% of the issuer's outstanding common stock.
• The beneficial ownership percentage is based on 5,268,708 shares of STRATA Skin Sciences, Inc. common stock issued and outstanding as of September 3, 2025.
• Lincoln Alternative Strategies LLC holds sole voting and sole dispositive power over all 365,849 shares.
• The filing certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates a significant passive investment by Lincoln Alternative Strategies LLC in STRATA Skin Sciences, suggesting institutional confidence without intent to influence control. This is generally a neutral to slightly positive signal for the issuer.

Positives

• The disclosure of a new significant institutional investor, Lincoln Alternative Strategies LLC, holding a 6.9% stake, may signal increased institutional confidence in STRATA Skin Sciences, Inc.

Risks

• The filing does not detail specific risks of the issuer, but rather the ownership structure. The certification that shares are not held for control purposes mitigates immediate concerns of activist investor intervention.

Future Outlook

The Schedule 13G filing does not provide any forward-looking statements or guidance regarding the issuer's future performance or strategic direction.

Industry Context

This filing represents a standard disclosure of a significant passive ownership stake by an investment firm in a publicly traded company. It indicates institutional interest in the dermatology and skin sciences sector, where STRATA Skin Sciences operates.

Comparison to Industry Standards

• Institutional ownership is a common feature in publicly traded companies across all industries. A 6.9% stake by an alternative strategies firm like Lincoln Alternative Strategies LLC is a notable, but not uncommon, level of institutional investment.
• The certification of passive intent aligns with typical Schedule 13G filings, differentiating it from Schedule 13D filings which indicate an intent to influence or control the issuer.

Corporate Governance

Stakeholder Impact

• Shareholders of STRATA Skin Sciences, Inc. may view the entry of a new institutional investor as a positive indicator of market confidence and potential for future value, potentially leading to increased trading interest.
• Company management may see this as validation of their current strategy, given the passive nature of the investment.

Key Dates

Recommendation

The disclosure of a new 6.9% passive stake by Lincoln Alternative Strategies LLC in STRATA Skin Sciences indicates institutional interest. While not a performance update, such a significant investment by an alternative strategies firm can be a positive signal for the company's long-term prospects, warranting a 'hold' for existing investors and further due diligence for potential new investors.

Keywords

STRATA Skin Sciences, Lincoln Alternative Strategies, Schedule 13G, beneficial ownership, common stock, institutional investment, dermatology, skin sciences